Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 16 de 16
Egyptian Journal of Anaesthesia ; 39(1):401-411, 2023.
Article in English | Web of Science | ID: covidwho-2322926


Background There were increased claims of thrombotic events in ICU-bound patients with COVID-19. We designed this observational study to examine implementation of systemic anti-coagulation on arterial catheter patency and its failure and to identify risk factors for arterial catheter failure. Methods A total of 245 COVID-19 subjects were included in this observational study, 48 patients in the non-systemic, (Non-SA), (Prophylactic) anticoagulation cohort, and 197 patients in the systemic (SA), (Therapeutic) anticoagulation group. The first arterial line inserted on ICU admission for every patient was monitored regarding its duration of the patency, number and location of consecutive arterial lines inserted during stay in ICU. Demographics of patients, ICU parameters and risk factors for arterial line failure were followed and analyzed. Results The percentage of arterial line failure was significantly higher in Non-SA group, 45.8% when compared to SA group, 25.9%, P = 0.007. The patients with arterial line failure exhibited higher D-dimer, co-morbidities, diabetic patients, received aspirin and mortality than the patent group, respectively, p = 0.002, p = 0.002, p < 0.0001, p < 0.0001, and p < 0.0001. This group also received higher sedation and prone position on mechanical ventilation and higher vasopressors, respectively, p = 0.034, p < 0.0001, p < 0.0001, and p < 0.0001 when compared to patent group. They had prolonged length of stay in ICU and hospital, respectively, p = 0.001 and p = 0.042. The cumulative incidence of index arterial line failure (Log-rank test 6.95, P = 0.008) with overall percentage was significantly lower in SA group (25.9%) compared to non-SA group (45.8%), respectively, P = 0.007. On Cox-proportional hazard multivariate regression analysis, independent predictors of arterial line failure increased platelets level (HR 1.00, 95% CI 1.00-1.01, P = 0.001), use of ultrasound use in arterial line insertion (HR 4.68, 95% CI 1.75-12.56, P = 0.002), and prone position in ICU (HR 1.94, 95% CI 1.09-3.42, P = 0.023). Conclusion We observed three independent predictors of arterial line failure including platelets level and ultrasound use during arterial catheter insertion and prone position in ICU. Systemic anticoagulation was associated with more patency of arterial catheter than prophylactic therapy group.

Asia Pacific Management Review ; 27(3):210-219, 2022.
Article in English | Web of Science | ID: covidwho-2310279
Economic Research-Ekonomska Istrazivanja ; 36(1):1040-1054, 2023.
Article in English | Scopus | ID: covidwho-2242390
European Psychiatry ; 65(Supplement 1):S133, 2022.
Article in English | EMBASE | ID: covidwho-2153821
Journal of Educational and Social Research ; 12(4):315-324, 2022.
Article in English | Scopus | ID: covidwho-1955589
NeuroQuantology ; 20(5):4359-4366, 2022.
Article in English | EMBASE | ID: covidwho-1918165
Economic Research-Ekonomska Istrazivanja ; : 15, 2022.
Article in English | English Web of Science | ID: covidwho-1882858
Journal, Indian Academy of Clinical Medicine ; 22(3-4):147-150, 2021.
Article in English | EMBASE | ID: covidwho-1576798
Asia Pacific Management Review ; 2021.
Article in English | Scopus | ID: covidwho-1560093
International Journal of Health and Allied Sciences ; 9:111-113, 2020.
Article in English | Web of Science | ID: covidwho-1106193
World Family Medicine ; 19(1):110-118, 2021.
Article in English | Web of Science | ID: covidwho-1059608
International Journal of Pharmacy and Pharmaceutical Sciences ; 12(8):1-10, 2020.
Article in English | EMBASE | ID: covidwho-743125


The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the extremely communicable viral infection coronavirus disease 19 (covid-19). Initially the virus was found at Wuhan, china which spread across the world exponentially and in a very short span. This outbreak has turned out to be a global health crisis and recently WHO regarded it as pandemic. The origin of the virus is predicted as either the natural selection in animal host prior to the transfer of the pathogen from animals to humans or the natural selection in humans and following transfer. Nevertheless, there is an extensive spread of virus by human to human transfer in the form of droplets. A few antiviral drugs are at the stage of clinical trials to eradicate the covid-19. In this review, a comprehensive approach is put forth to scrutinise the etiology, pathogenicity and transmission of SARS CoV-2. The review also deliberates broadly on the diagnosis and status of therapeutic treatment developed. It also focuses on the preventive and controlling measures from different sectors of the society. The review covers the details reported in 70 studies which were chosen after keyword searches carried out leading to over 884 resulting articles.